CNN distinguishes pancreatic cancer on contrast CT with cross-racial validation
A CNN trained on contrast-enhanced CT from a Taiwanese centre reached 98.3% sensitivity on combined local test sets versus 92.9% for radiologists (difference 5.4 points, p=0.014). On a US external test set, sensitivity fell to 79.0% with specificity 97.6% (AUC 0.920), and sensitivity for tumours under 2 cm was 63.1% in that set. The study is retrospective and the authors describe it as supplementary to radiologists.
Technology: Convolutional neural network applied to CT image patches
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: A CNN trained on Taiwanese contrast CT was tested on local test sets against radiologists and on an external US test set, where it reached 79.0% sensitivity and 97.6% specificity.
- Still unknown: The study is retrospective; sensitivity for tumours under 2 cm was 63.1% on the US set, and radiologist comparisons covered only the local sets.
- AI role: A CNN classified image patches as cancerous and labelled each patient by the proportion of cancerous patches; the authors describe it as supplementary to radiologists.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33328124%20AND%20SRC:MED&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 233 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.